FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Rafal Slusarz

Research Profile

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Magdalena J Slusarz; Emilia Sikorska; Rafal Slusarz
Interactions of vasopressin and oxytocin receptors with vasopressin analogues substituted in position 2 with 3,3'-diphenylalanine--a molecular docking study.
Emilia Sikorska; Anna Kwiatkowska; Dariusz Sobolewski; Rafal Slusarz; Magdalena J Slusarz
Influence of bulky 3,3'-diphenylalanine enantiomers replacing position 2 of AVP analogues on their conformations: NMR and molecular modeling studies.
Szymon Zietkiewicz; Magdalena J Slusarz; Rafal Slusarz; Krzysztof Liberek; Sylwia Rodziewicz-Motowidło
Conformational stability of the full-atom hexameric model of the ClpB chaperone from Escherichia coli.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Rafal Slusarz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Magdalena J Slusarz; Emilia Sikorska; Rafal Slusarz
Interactions of vasopressin and oxytocin receptors with vasopressin analogues substituted in position 2 with 3,3'-diphenylalanine--a molecular docking study.
Journal of peptide science : an official publication of the European Peptide Society 2013;19(2):118-26.
2010: Emilia Sikorska; Anna Kwiatkowska; Dariusz Sobolewski; Rafal Slusarz; Magdalena J Slusarz
Influence of bulky 3,3'-diphenylalanine enantiomers replacing position 2 of AVP analogues on their conformations: NMR and molecular modeling studies.
European journal of medicinal chemistry 2010;45(9):4065-73.
2010: Szymon Zietkiewicz; Magdalena J Slusarz; Rafal Slusarz; Krzysztof Liberek; Sylwia Rodziewicz-Motowidło
Conformational stability of the full-atom hexameric model of the ClpB chaperone from Escherichia coli.
Biopolymers 2010;93(1):47-60.
2009: Magdalena J Slusarz; Rafal Slusarz; Jerzy Ciarkowski
Molecular dynamics study of the internal water molecules in vasopressin and oxytocin receptors.
Protein and peptide letters 2009;16(4):342-50.
2006: Magdalena J Slusarz; Emilia Sikorska; Rafal Slusarz; Jerzy Ciarkowski
Molecular docking-based study of vasopressin analogues modified at positions 2 and 3 with N-methylphenylalanine: influence on receptor-bound conformations and interactions with vasopressin and oxytocin receptors.
Journal of medicinal chemistry 2006;49(8):2463-9.
2006: Magdalena J Slusarz; Rafal Slusarz; Jerzy Ciarkowski
Investigation of mechanism of desmopressin binding in vasopressin V2 receptor versus vasopressin V1a and oxytocin receptors: molecular dynamics simulation of the agonist-bound state in the membrane-aqueous system.
Biopolymers 2006;81(5):321-38.
2006: Magdalena J Slusarz; Artur Giełdoń; Rafal Slusarz; Jerzy Ciarkowski
Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors-molecular dynamics study of the activated receptor-vasopressin-G(alpha) systems.
Journal of peptide science : an official publication of the European Peptide Society 2006;12(3):180-9.
2006: Magdalena J Slusarz; Rafal Slusarz; Jerzy Ciarkowski
Molecular dynamics simulation of human neurohypophyseal hormone receptors complexed with oxytocin-modeling of an activated state.
Journal of peptide science : an official publication of the European Peptide Society 2006;12(3):171-9.
2006: Emilia Sikorska; Magdalena J Slusarz; Rafal Slusarz; Wioleta Kowalczyk; Bernard Lammek
Investigation of cis/trans ratios of peptide bonds in AVP analogues containing N-methylphenylalanine enantiomers.
Journal of peptide science : an official publication of the European Peptide Society 2006;12(1):13-24.
2005: Emilia Sikorska; Rafal Slusarz; Bernard Lammek
Conformational studies of highly potent 1-aminocyclohexane-1-carboxylic acid substituted V vasopressin agonists.
The journal of peptide research : official journal of the American Peptide Society 2005;66 Suppl 1():30-40.
2005: E Sikorska Trzepałka; Rafal Slusarz; Bernard Lammek
Conformational studies of two bradykinin antagonists by using two-dimensional NMR techniques and molecular dynamics simulations.
Journal of biomolecular structure & dynamics 2005;23(2):125-34.
2005: Jerzy Ciarkowski; Magdalena Witt; Rafal Slusarz
A hypothesis for GPCR activation.
Journal of molecular modeling 2005;11(4-5):407-15.
2004: Rafal Slusarz; Jerzy Ciarkowski
Interaction of class A G protein-coupled receptors with G proteins.
Acta biochimica Polonica 2004;51(1):129-36.
2003: Artur Giełdoń; Rajmund Kaźmierkiewicz; Rafal Slusarz; Marta Pasenkiewicz-Gierula; Jerzy Ciarkowski
Molecular dynamics study of 4-OH-phenylacetyl- D-Y(Me)FQNRPR-NH2 selectivity to V1a receptor.
Journal of molecular modeling 2003;9(6):372-8.
2003: Magdalena J Slusarz; Rafal Slusarz; Rajmund Kaźmierkiewicz; Jerzy Trojnar; Kazimierz Wisniewski; Jerzy Ciarkowski
Molecular modeling of the neurohypophyseal receptor/atosiban complexes.
Protein and peptide letters 2003;10(3):295-302.
2001: A Giełdoń; R Kaźmierkiewicz; Rafal Slusarz; Jerzy Ciarkowski
Molecular modeling of interactions of the non-peptide antagonist YM087 with the human vasopressin V1a, V2 receptors and with oxytocin receptors.
Journal of computer-aided molecular design 2001;15(12):1085-104.
2001: Jerzy Ciarkowski; Piotr Drabik; A Giełdoń; R Kaźmierkiewicz; Rafal Slusarz
Signal transmission via G protein-coupled receptors in the light of rhodopsin structure determination.
Acta biochimica Polonica 2001;48(4):1203-7.
2001: Rafal Slusarz; R Kaźmierkiewicz; A Giełdoń; Bernard Lammek; Jerzy Ciarkowski
Molecular docking-based test for affinities of two ligands toward vasopressin and oxytocin receptors.
Acta biochimica Polonica 2001;48(1):131-5.
2000: Rafal Slusarz; R Kaźmierkiewicz; Bernard Lammek
Theoretical conformational analysis of six arginine vasopressin analogs with the L-naphthylalanine in position 3.
The journal of peptide research : official journal of the American Peptide Society 2000;56(6):352-9.